Inhibition of MMP-2 and MMP-9 attenuates surgery-induced cognitive impairment in aged mice

Yiqin Ji1, Wanbo Huang2, Yijun Chen1

  • 1Department of Anesthesiology, The First Affiliated Hospital of Ningbo University, Ningbo 315010, Zhejiang, China.

Brain Research Bulletin
|November 8, 2023
PubMed
Abstract

Insights

Inhibiting matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, can help prevent cognitive decline after surgery and anesthesia. This approach improves brain barrier integrity and reduces inflammation, offering a potential treatment for perioperative neurocognitive disorders (PND).

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • Perioperative neurocognitive disorders (PND) are linked to increased matrix metalloproteinase (MMP) expression in the hippocampus.
  • The specific role of inhibiting MMP-2 and MMP-9 in PND remains unclear.
  • This study investigates MMP inhibition as a potential therapeutic strategy for PND.

Purpose of the Study:

  • To evaluate the effect of inhibiting MMP-2 and MMP-9 on cognitive function in aged mice following surgery.
  • To identify potential therapeutic targets for the prevention and treatment of PND.

Main Methods:

  • A PND model was established in 14-month-old C57BL/6 mice using tibial fracture surgery and sevoflurane anesthesia.
  • Cognitive function was assessed using the Novel Object Recognition and Fear Conditioning tests.
  • MMP-2, MMP-9, claudin-5, and occludin expression were analyzed via Western blotting; glial cell activation was assessed using immunofluorescence.

Main Results:

  • Surgery induced cognitive impairment, increased hippocampal MMP-2 and MMP-9 expression, decreased claudin-5 and occludin levels, and elevated microglial and astrocyte activation.
  • Treatment with SB-3CT, an MMP inhibitor, reversed these surgery-induced changes.
  • Inhibition of MMP-2 and MMP-9 demonstrated a protective effect against PND.

Conclusions:

  • Inhibition of MMP-2 and MMP-9 alleviates surgery- and anesthesia-induced cognitive decline.
  • This neuroprotective effect is mediated by enhanced blood-brain barrier (BBB) integrity and suppressed glial cell activation.
  • Targeting MMP-2 and MMP-9 presents a promising therapeutic avenue for PND.

Related Concept Videos